The Frontier Psychiatrists

The Frontier Psychiatrists

Share this post

The Frontier Psychiatrists
The Frontier Psychiatrists
Lurasidone
Copy link
Facebook
Email
Notes
More

Lurasidone

An atypical antipsychotic that sucks...less!

Owen Scott Muir, M.D's avatar
Owen Scott Muir, M.D
Sep 02, 2023
∙ Paid
5

Share this post

The Frontier Psychiatrists
The Frontier Psychiatrists
Lurasidone
Copy link
Facebook
Email
Notes
More
1
Share

This is the second edition in my “farewell to oral meds” articles, welcome to “Lurasidone.” (Trade Name: Latuda)

This is The Frontier Psychiatrists Newsletter. It is a one-person daily health-related adventure in writing. Please subscribe—the once-a-day articles are almost always free, but older some real gems that might change your life1 are locked away behind a paywall! What is in there? Could your life be better? Yes2. However, without taking the step3 of subscribing, you will never know.

It is worth noting for new readers that this daily newsletter often uses satire because it is more fun. Also, I have stalkers—yes, I do. This is common for doctors, particularly psychiatrists. My stalkers have a limited grasp of sarcasm. So that tone? It is my shield, more or less.

All of the standard caveats about atypical antipsychotics aside, Lursaidone has some differences with other agents…

Lurasidone!

From a safety and efficacy standpoint, Lurisdone has FDA approval for treating bipol…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 The Frontier Psychiatrists
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More